The company has received approval from FDA (Food and Drugs Administration) Gandhi Nagar, Gujarat (India), to manufacture and market Posaconazole API as approved medication for treating Mucormycosis in India, Bajaj Healthcare said in a regulatory filing.Bajaj Healthcare launches drug to treat black fungus infection in COVID-19 patients
The company has received approval from FDA (Food and Drugs Administration) Gandhi Nagar, Gujarat (India), to manufacture and market Posaconazole API as approved medication for treating Mucormycosis in India, Bajaj Healthcare said in a regulatory filing.
Subscribe to:
Post Comments (Atom)
-
Market-men said the fall in gold prices at futures trade was mostly due to trimming of positions by participants.
-
Thirteen tier 2 and 3 cities register higher traffic in December than pre-COVID-19 levels.
-
The NCLT#39;s Ahmedabad bench has directed the RP to include GAIL in the list of creditors for both the companies.
No comments:
Post a Comment